Surgery

Oncology·MeSH: Agnosia
81 drugs in development·57 companies·19 clinical trials

Drug Pipeline by Phase

Approved(51)
DrugCompany
600 series dye modules and series 700 and 800 ktp/532 and ktp/yag surgical lasersAmerican Cannabis Company, Inc. (AMMJ)
acetazolamideACHIEVE LIFE SCIENCES, INC. (ACHV)
acetazolamidePrestige Consumer Healthcare Inc. (PBH)
acetazolamideGreenwich LifeSciences, Inc. (GLSI)
acetazolamideMylan II B.V. (MYL)
acetazolamideACADIA PHARMACEUTICALS INC (ACAD)
acetazolamideMANNKIND CORP (MNKD)
afinitorNovartis AG (NVS)
apixabanMylan II B.V. (MYL)
apixabanImpax Laboratories, LLC (IPXL)
apligrafOrganogenesis Holdings Inc. (ORGO)
BridionMerck & Co., Inc. (MRK)
bromfenacAmneal Pharmaceuticals, Inc. (AMRX)
bromfenacAptinyx Inc. (APTX)
bupivacaineSpero Therapeutics, Inc. (SPRO)
byqloviHARROW, INC. (IMMY)
chenodiolOptec International, Inc. (GM)
clobetasol propionate ophthalmic suspension 0.05%HYPERION DEFI, INC. (HYPD)
elevessAnika Therapeutics Inc. (ANIK)
enoxaparinAmphastar Pharmaceuticals, Inc. (AMPH)
ErivedgeCURIS INC (CRIS)
ermezaMylan II B.V. (MYL)
extended phenytoinSUNSET ISLAND GROUP (SUN)
fosphenytoinAmneal Pharmaceuticals, Inc. (AMRX)
heparinPFIZER INC (PFE)
ilevroHARROW, INC. (IMMY)
indermil tissue adhesiveUNITED CANNABIS CORP (CNAB)
Indometacin and Furazolidone SuppositoriesChina Health Industries Holdings, Inc. (CHHE)
juvederm injectable gel implantsAllergan plc (AGN)
kxl system + photrexa formulationsAVEDRO INC (AVDR)
lidocaineANTHERA PHARMACEUTICALS INC (ANTH)
metyrosineAmneal Pharmaceuticals, Inc. (AMRX)
neostigmine methylAmphastar Pharmaceuticals, Inc. (AMPH)
nocitaARATANA THERAPEUTICS, INC. (PETX)
opdivo qvantigBRISTOL MYERS SQUIBB CO (BMY)
ovitex prsTELA Bio Inc. (TELA)
palonosetronTeva Pharmaceutical Industries Limited (TEVA)
perclot polysaccharide hemostatic systemBaxter International Inc. (BAX)
preveleak surgical sealantBaxter International Inc. (BAX)
propylgallateCHINA PHARMA HOLDINGS, INC. (CPHI)
Propylgallate for InjectionCHINA PHARMA HOLDINGS, INC. (CPHI)
radiesse injectable implantAMERICA GREAT HEALTH (CWNM)
RecorlevXeris Biopharma Holdings, Inc. (XERS)
sculptraQ BioMed Inc. (QBIO)
sodium nitroprussideNEXUS BIOPHARMA INC (NEXS)
succinylcholineNEXUS BIOPHARMA INC (NEXS)
transcyteSHIRE PLC (SHPGF)
unloxcytCheckpoint Therapeutics, Inc. (CKPT)
unloxcytFortress Biotech Inc. (FBIO)
unloxcytFortress Biotech Inc. (FBIO)
ursodiolOptec International, Inc. (GM)

Compare drugs

Frequently asked questions

How many drugs are in development for Surgery?

BioSniper tracks 81 drugs in development for Surgery across 57 companies.

How many clinical trials target Surgery?

There are 19 clinical trials targeting Surgery tracked by BioSniper.

Deep-dive into Surgery

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Surgery — Drugs in Development & Clinical Trials | BioSniper